Cable Hill Partners, LLC Novartis Ag Transaction History

Cable Hill Partners, LLC

$964 Million
Q3 2024

A detailed history of Cable Hill Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Cable Hill Partners, LLC holds 11,933 shares of NVS stock, worth $1.16 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

11,933

Previous 11,383 4.83%

Holding current value

$1.16 Million

Previous $1.21 Million 13.29%

% of portfolio

0.14%

Previous 0.14%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$106.13 - $120.89 $58,371 - $66,489	550 Added 4.83%	11,933 $1.37 Million
Q2 2024 Jul 22, 2024	BUY	$92.57 - $107.37 $1.05 Million - $1.22 Million	11,383 New	11,383 $1.21 Million
Q3 2023 Oct 27, 2023	BUY	$94.73 - $105.13 $184,439 - $204,688	1,947 Added 23.92%	10,088 $1.03 Million
Q2 2023 Jul 19, 2023	BUY	$92.52 - $104.91 $67,632 - $76,689	731 Added 9.87%	8,141 $821,000
Q1 2023 May 04, 2023	SELL	$80.03 - $92.81 $272,342 - $315,832	-3,403 Reduced 31.47%	7,410 $681,000
Q4 2022 Feb 06, 2023	BUY	$75.55 - $92.52 $211,917 - $259,518	2,805 Added 35.03%	10,813 $980,000
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $23,576 - $27,574	-316 Reduced 3.8%	8,008 $609,000
Q2 2022 Aug 11, 2022	BUY	$80.52 - $93.75 $114,660 - $133,500	1,424 Added 20.64%	8,324 $704,000
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $49,988 - $56,546	624 Added 9.94%	6,900 $605,000
Q4 2021 Feb 11, 2022	BUY	$79.7 - $88.13 $65,752 - $72,707	825 Added 15.13%	6,276 $549,000
Q3 2021 Nov 16, 2021	BUY	$81.78 - $95.14 $61,498 - $71,545	752 Added 16.0%	5,451 $446,000
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $21,736 - $24,008	-255 Reduced 5.15%	4,699 $429,000
Q1 2021 May 17, 2021	BUY	$83.5 - $98.47 $52,939 - $62,429	634 Added 14.68%	4,954 $423,000
Q4 2020 Feb 09, 2021	SELL	$78.07 - $94.43 $11,710 - $14,164	-150 Reduced 3.36%	4,320 $408,000
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $24,683 - $27,785	-305 Reduced 6.39%	4,470 $390,000
Q1 2020 May 14, 2020	BUY	$70.67 - $99.01 $5,441 - $7,623	77 Added 1.64%	4,775 $394,000
Q4 2019 Feb 04, 2020	SELL	$84.35 - $95.37 $108,895 - $123,122	-1,291 Reduced 21.56%	4,698 $445,000
Q3 2019 Oct 29, 2019	SELL	$85.54 - $94.26 $60,476 - $66,641	-707 Reduced 10.56%	5,989 $520,000
Q2 2019 Aug 06, 2019	SELL	$75.4 - $92.8 $245,276 - $301,878	-3,253 Reduced 32.7%	6,696 $611,000
Q1 2019 May 10, 2019	SELL	$75.32 - $86.15 $110,871 - $126,812	-1,472 Reduced 12.89%	9,949 $956,000
Q4 2018 Feb 12, 2019	BUY	$73.66 - $82.02 $793,391 - $883,437	10,771 Added 1657.08%	11,421 $980,000
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $17,739 - $20,518	-265 Reduced 28.96%	650 $56,000
Q2 2018 Aug 03, 2018	BUY	$64.91 - $73.36 $4,154 - $4,695	64 Added 7.52%	915 $69,000
Q1 2018 Apr 20, 2018	SELL	$70.39 - $84.15 $4,716 - $5,638	-67 Reduced 7.3%	851 $68,000
Q4 2017 Feb 22, 2018	SELL	$72.33 - $77.64 $27,268 - $29,270	-377 Reduced 29.11%	918 $79,000
Q3 2017 Oct 27, 2017	BUY	$74.14 - $77.27 $82,072 - $85,537	1,107 Added 588.83%	1,295 $112,000
Q2 2017 Aug 14, 2017	BUY	N/A	188	188 $15,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cable Hill Partners, LLC with notifications on news.

Account

Cable Hill Partners, LLC Novartis Ag Transaction History